Nalaganje...

Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy

BACKGROUND: Specific immunotherapy is the only type of disease-modifying treatment, which induces rapid desensitization and long-term sustained unresponsiveness in patients with seasonal allergic rhinoconjunctivitis. The safety and tolerability of a new cumulative dose regimen of 35600 SU Grass MATA...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:World Allergy Organ J
Main Authors: Starchenka, Sviatlana, Heath, Matthew D., Lineberry, Alyson, Higenbottam, Tim, Skinner, Murray A.
Format: Artigo
Jezik:Inglês
Izdano: World Allergy Organization 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6872854/
https://ncbi.nlm.nih.gov/pubmed/31768216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2019.100087
Oznake: Označite
Brez oznak, prvi označite!